Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sara Aida Jiménez-Julià"'
Autor:
Marta García-Recio, Javier Ibarra, Leyre Bento, Adriana Marcela Quintero, Gaspar Aspas, Antonia Sampol, Regina Alemany, Blanca Sanchez-Gonzalez, Teresa Ros, Concepción Fernández, Rafael Yus Ramos, Oliver Vögler, Josep Muncunill, Sara Aida Jiménez-Julià, Adriana Sas, Jordi Martinez-Serra, Sandra Pérez, Antonio Salar, Raquel Del Campo, Víctor Asensio, Antonio Gutierrez
Publikováno v:
Blood. 134:1627-1627
Introduction: Micro-RNAs (miRNAs) are 19-24 nucleotide non-coding RNAs that regulate gene expression through the inactivation of their messenger RNA. Previous studies have demonstrated the important role of some miRNAs in the development of cancer. S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a7178e4cb97234a528893577e688b2b
https://doi.org/10.1182/blood-2019-130544
https://doi.org/10.1182/blood-2019-130544
Autor:
B. Andrade, Sandra Pérez León, Laura Lo Riso, Javier Vercher, Maria Antonia Duran Pastor, Júlia Domíngez Esteve, Antonia Sampol, Beltran Serra Neus, Sofía Villaverde, Sara Aida Jiménez-Julià, Ros Matheu Teresa, Albert Pérez Montaña, Josep Muncunill Farreny, Jose Maria Sanchez Raga
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e178
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84711e1c6f1a41c19096738d6a63f0f4
https://doi.org/10.1016/j.clml.2019.09.298
https://doi.org/10.1016/j.clml.2019.09.298
Autor:
Sandra Pérez-León, Jordi Gines, Antonia Sampol, Marta Garcia Recio, Sara Aida Jiménez-Julià, Leyre Bento, Jordi Martinez-Serra, Antonio Gutierrez
Publikováno v:
Blood. 132:5337-5337
Introduction: Six percent of all non-Hodgkin lymphomas (NHL) cases are mantle cell lymphoma (MCL). MCL has a poor prognosis and is considered incurable with current strategies. Intensive approaches are not applicable to most these patients considerin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::341eebc17961a2e49424c75931cbb83e
https://doi.org/10.1182/blood-2018-99-119713
https://doi.org/10.1182/blood-2018-99-119713
Autor:
Lucia García, Antonia Sampol, Blanca Sanchez-Gonzalez, Marta Garcia Recio, Antonio Gutierrez, Leyre Bento, Antonio Salar, Jordi Gines, Beatriz Robredo, Sandra Pérez-León, Sara Aida Jiménez-Julià, Jordi Martinez-Serra
Publikováno v:
Blood. 132:5339-5339
Introduction : Follicular lymphoma (FL) is an indolent non-Hodgkin lymphoma that represents 15-30% of all newly diagnosed lymphomas. It is characterized by a high rate of response followed by continuous relapses being considered incurable with standa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e11a79158494b518abb5465630a6335
https://doi.org/10.1182/blood-2018-99-119551
https://doi.org/10.1182/blood-2018-99-119551
Autor:
Paloma López Perezagua, Gaspar Aspas, Jordi Martinez-Serra, Antonia Sampol, Francesc Mestre, Jaume Daumal, Rafael Yus Ramos, Sara Aida Jiménez-Julià, Antonio Gutierrez, Adriana Marcela Quintero, Leyre Bento, Lucia García, Marta Garcia Recio, Sandra Pérez
Publikováno v:
Blood. 132:1710-1710
INTRODUCTION The standard first line treatment for patients with diffuse large B-cell lymphoma (DLBCL) is rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) independently of cell origin subtype. Retrospective studies have s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3072d3a8bb23820b9979224b3258bc19
https://doi.org/10.1182/blood-2018-99-119138
https://doi.org/10.1182/blood-2018-99-119138